Vir Biotechnology Inc (VIR) — Long-term Investment Intensity
Vir Biotechnology Inc (VIR) has a Long-term Investment Intensity of 32.5% as of March 2026. Long-term investments of $332.97 Million represent 32.5% of total assets of $1.03 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Vir Biotechnology Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Vir Biotechnology Inc Long-term Investment Intensity (2018–2025)
This chart shows how Vir Biotechnology Inc's Long-term Investment Intensity has evolved across 7 annual periods from 2018 to 2025. As of March 2026, the intensity stands at 32.5%, reflecting long-term investments of $332.97 Million against total assets of $1.03 Billion USD. Explore Vir Biotechnology Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Vir Biotechnology Inc (2018–2025)
The table below presents the year-by-year Long-term Investment Intensity for Vir Biotechnology Inc from 2018 to 2025, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Vir Biotechnology Inc (VIR) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 31.4% | $314.57 Million | $1.00 Billion | ▲ +17.8 pp |
| 2024 | 13.6% | $190.01 Million | $1.40 Billion | ▲ +8.1 pp |
| 2023 | 5.5% | $105.28 Million | $1.92 Billion | ▲ +4.6 pp |
| 2022 | 0.9% | $23.93 Million | $2.80 Billion | ▼ -9.5 pp |
| 2021 | 10.3% | $201.39 Million | $1.95 Billion | ▲ +5.6 pp |
| 2019 | 4.7% | $24.29 Million | $512.07 Million | ▲ +1.3 pp |
| 2018 | 3.4% | $6.60 Million | $191.60 Million | — |